1518586330325917697

Only 16-19% of Black cancer patients access an appropriate donor match for transplant. At #Tandem22, we shared data showing our investigational product, omidubicel helped to reduce racial disparities, improving health equity in allo-HSCT care. More here: https://t.co/fEUfvVbnQn https://t.co/53VroLcKj6

Send us a message